<DOC>
	<DOCNO>NCT00652015</DOCNO>
	<brief_summary>In-Stent-Thrombosis rare serious complication implantation stent PTCA .</brief_summary>
	<brief_title>Molecular Cellular Mechanisms In-stent-thrombosis</brief_title>
	<detailed_description>In prospective , open , not-randomized , control single-center pilot study 80 patient in-stent-thrombosis ( 40 sub-acute thromboses ( SAT ) , 40 late thromboses ( LT ) ) control group 80 patient develop thrombosis compare . The aim study establishment diagnostic marker vor prediction SAT ( detection CD39- CD73-activity , respectively ) LT ( EPC-number function , respectively ) correspondingly aim early identification patient high risk develop in-stent-thrombosis .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<criteria>patient develop SAT LT stent implantation use PTCA instabel coronary heart disease , systemic autoimmune disease , rheumatic disease , tumor , impaired kidney liver function , surgery within last 3 month , pregnant lactating woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>in-stent-thrombosis</keyword>
	<keyword>CD39</keyword>
	<keyword>CD73</keyword>
	<keyword>EPC</keyword>
</DOC>